Together We Build Dreams
A fresh approach
Veramed has grown from a team of just 3 from its inception in 2012 to an expansive team based in our head office in Twickenham, London, the BioHub in Manchester, Swansea in South Wales and Boston in the US. Our team is comprised of highly skilled statisticians, programmers, directors and managers who have all been carefully recruited and who each bring not only technical excellence to every project, but commercial intelligence too.
Executive Leadership Team
Katherine’s particular interest is client relationship management: supporting and developing requirements to support the client needs, backed up with excellent project and budget management.
Katherine has an MSc in Applied Statistics (1994, Sheffield Hallam University) and a BSc in Mathematics (1986, Leeds University). As an active member of Statisticians in Pharmaceutical Industry (PSI), Katherine has held positions on their Board of Directors, including Chair (2011-2012).
Emma has a wealth of experience in vendor oversight, statistical consultancy and of clinical statistical analysis gained from a variety of leading global pharmaceutical companies. She has knowledge in both technical and non-technical aspects of study design and statistical analysis across clinical studies from Phase I-III and multiple therapeutic areas, including oncology, respiratory and immunology.
Emma holds a PhD in Statistics and is an active member of Statisticians in Pharmaceutical Industry (PSI). Emma was the Conference Chair for the 2015 and 2016 annual conference in London and Berlin, respectively.
Matthew began his pharmaceutical career in SAS programming with Oxford Pharmaceutical Sciences (now Quanticate), where he honed his technical skills through various positions of ascending seniority. He subsequently worked in a variety of freelance and permanent programming positions across the industry for both CRO and large Pharma, and developed a deep working knowledge of several different outsourcing models.
Matthew holds a BSc in Economics from the University of Nottingham (1999) and an executive MBA from Cranfield University (2006).
He started his career in 2007 at James Harvard, a specialist pharmaceutical recruitment business, before it was acquired by Hays, where he continued to develop until 2013. He subsequently moved to another specialist recruitment firm before taking the decision to move to Veramed. He is predominantly responsible for oversight of key client portfolios and helping to drive business forward at Veramed.
Kien-Sen has a BSc in Biochemistry (2006, Kings College London) and has been regularly attending the PHUSE and PSI conferences over the past 10 years.
Stuart has over 20 years of Pharmaceutical experience having first started work in anti-malaria research which took him to Moshi, Tanzania. He then moved to the Clinical Research Organisation Chiltern (latterly Covance) where he took on Business Development, Leadership and Alliance Partnership roles delivering significant growth over 19 years. Stuart has a wide platform of relationships in the pharmaceutical and biotech industry, covering Europe, North America and Japan.
Stuart holds a BSc in Chemistry from the University of Surrey (1999) and recently received his level III wine diploma from the Wines and Spirits Education Trust.
Charlie read law before working in the finance industry for 7 years, latterly as Director of Corporate Finance at VSA Capital where he developed his technical investment appraisal skills and learned the process of raising capital for companies privately and publicly.
Charlie trained as a management accountant, working at Premier Inn for five years in various positions of ascending seniority in the Financial Planning & Analysis, Financial Control and Investments Teams. He worked as an accounting consultant and tax adviser before joining Veramed in 2020.
Charlie is a Mandarin speaker, a Chartered Management Accountant (2016), a non-registered barrister (2006) and holds a BA from Sheffield University (2001).
Alexander worked in leading positions for sponsors over the first 2 decades of the century in various indications including immunology, virology, neuroscience, urology, respiratory, and psychiatry. He has expertise across all clinical phases. Since 2004, he has concentrated on successfully launching and commercializing new treatments.
Alexander holds a PhD in Biostatistics and is an active member of Statisticians in Pharmaceutical Industry (PSI) where he served on the board of directors, founded and chaired the Visualization Special Interest group, chaired the Benefit-Risk Special Interest group, and contributed to many conferences, webinars, and one-day-events.
In 2018, he launched The Effective Statistician podcast in association with PSI in which he shares his insights around leadership, innovation, knowledge, and excellence required for a successful career in the healthcare industry. Dozens of guests across the industry and beyond helped to create a wealth of content to serve the statistical community.
Functional Management Team
She has held various positions of ascending seniority and has led Global Programming Teams across multiple therapeutic areas and clinical trial phases from Phase I through to Phase IV.
She has significant experience in Late Development Oncology, Cardiovascular and Infectious disease therapy areas.
She has extensive experience in project management, and has overseen and driven the delivery of programming activities across multiple programs simultaneously, including submission deliverables, regulatory defence and reimbursement activities.
Vicki has a BSc in Biochemistry from Lancaster University (1995).
His expertise includes clinical biostatistics; clinical study design, reporting and logistics; imaging informatics and medical image analysis, with applications in multiple therapeutic areas including neuroscience, cardiovascular, oncology and respiratory.
He also has detailed understanding of computing infrastructures, having been involved in software development, training and support.
Formally trained in pure mathematics (BSc, University of Durham, 1990) and statistics (MSc, University of Sheffield, 1991), Andrew gained a PhD from the University of Glasgow in 1994 for research into statistical methods for functional neuroimaging. He has co-authored numerous publications, book chapters and software packages.
Leveraging 20 years of programming expertise across the pharmaceutical sector, Diana is one of the critical success factors behind the Veramed Graduate Training Programme, which she set up and coordinates each year. Alongside this challenging role, Diana supports employee engagement activities, ensures consistency in approach and advises on line management styles to foster and encourage valued contributions across the company as a whole.
Diana has been actively involved with Pharmaceutical Users Software Exchange (PHUSE) since 2009, editing and contributing to the PHUSE quarterly newsletter and more recently contributing to the PHUSE blogs, as well as active participation in the EU conference across the Professional Development, Industry Starters, University Day and Poster streams. In 2018, Diana was honoured to be made a Lifetime Honorary Member of receive a Lifetime achievement for PHUSE for her significant contribution to the organisation over a number of years.
Diana’s roles have allowed exposure to multiple therapeutic areas and clinical trial phases from Phase I through to Phase IV. She has significant experience in Early Development and Phase I to III Oncology.
Clare has an MSc in Medical Statistics (2005, University of Leicester) with a first degree in Natural Sciences (1995, University of Cambridge).
Louise headed up marketing of late phase and comercialisation services for a global CRO, before setting up her own consultancy which she managed for seven years. This gave her unique experience of a cross-section of projects and services that she applies to her role within Veramed. Her responsibilities include marketing strategy, external and internal communications, branding and cultural development.
Louise holds a BA (Hons) in English (Queen Mary, University of London, 2007) and various marketing qualifications including a Diploma in Marketing (Oxford College of Marketing, 2010).
Jamie has a broad experience of working within a CRO – both at a small Phase I unit as well as Global CROs – progressing through the ranks to manager level. His varied career has given him exposure working on various phases and therapeutic areas.
With a proven track record in line management, Jamie is well placed to support Veramed’s expansion and lead the South Wales office in Swansea.
Annie uses her wealth of experience, outstanding organisational skills and attention to detail to effectively manage the day-to-day running of Veramed.
Annie achieved a Post-graduate Diploma in Management Studies (1998, The University of Reading) and holds a BA(Hons) in International Business with German (1995, Sheffield Hallam University).
Mark is passionate about delivering IT systems that add real value to an organisation, working with business stakeholders to define requirements and deliver high quality, high value solutions which he is able to do through his combined pharmaceutical and Consultancy experience.
Mark has an MSc in Medical Statistics (2002, London School of Hygiene and Tropical Medicine) and a BSc in Mathematics, Statistics and Operational Research (2001, University of Wales). Mark holds several SAS certifications, and has previously been a member of the Statisticians in the Pharmaceutical Industry (PSI) Board of Directors.
Her varied career has allowed her to develop a broad business skill set including project management, business analysis, systems implementation, service management, process design and contract management.
Lisa utilises her blend of technical, organisational and analytical skills to manage the Client Proposals and Contracts function at Veramed, joining our client facing and internal processes together.
Get in touch
Talk to us about your needs
We pride ourselves on providing a perfect service that meets your requirements and is also dynamic to adapt to changes in scope. That’s why we discuss your needs in detail to understand the type of service that will suit you.